T0	Participants 64 100	patients with systolic heart failure
T1	Participants 231 249	left heart failure
T2	Participants 596 638	patients with left systolic heart failure.
T3	Participants 729 801	106 patients were randomized 1:1 to sildenafil (n=53) or placebo (n=53).
T4	Participants 802 947	Patients received sildenafil 25 mg twice a day or matching placebo for the first 2 weeks and 50 mg 3 times a week for the remainder of the trial.
T5	Participants 1434 1461	left heart failure patients